Cross-Presentation Pathway Cooperate in a MHC-I Antigen HLA-F and MHC-I Open Conformers

[1]  O. Joffre,et al.  Cross-presentation by dendritic cells , 2012, Nature Reviews Immunology.

[2]  Sarah Seifert,et al.  Rab5 is necessary for the biogenesis of the endolysosomal system in vivo , 2012, Nature.

[3]  Sven Burgdorf,et al.  Cross-Presentation: How to Get there – or How to Get the ER , 2012, Front. Immun..

[4]  J. Neefjes,et al.  Towards a systems understanding of MHC class I and MHC class II antigen presentation , 2011, Nature Reviews Immunology.

[5]  C. Szymanski,et al.  Endo-Lysosomal Vesicles Positive for Rab7 and LAMP1 Are Terminal Vesicles for the Transport of Dextran , 2011, PloS one.

[6]  D. Geraghty,et al.  HLA‐F is a surface marker on activated lymphocytes , 2010, European journal of immunology.

[7]  D. Geraghty,et al.  HLA-F Complex without Peptide Binds to MHC Class I Protein in the Open Conformer Form , 2010, The Journal of Immunology.

[8]  C. Yee,et al.  Conditional Superagonist CTL Ligands for the Promotion of Tumor-Specific CTL Responses , 2010, The Journal of Immunology.

[9]  James McCluskey,et al.  The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length. , 2009, Molecular immunology.

[10]  Jacopo Meldolesi,et al.  Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.

[11]  P. Lindner,et al.  Urea-Mediated Cross-Presentation of Soluble Epstein-Barr Virus BZLF1 Protein , 2008, PLoS pathogens.

[12]  P. Cresswell,et al.  Regulation of MHC class I assembly and peptide binding. , 2008, Annual review of cell and developmental biology.

[13]  W. Jefferies,et al.  MHC Class I Endosomal and Lysosomal Trafficking Coincides with Exogenous Antigen Loading in Dendritic Cells , 2008, PloS one.

[14]  Syed M. Rizvi,et al.  MHC class I assembly: out and about. , 2008, Trends in immunology.

[15]  Hidde L. Ploegh,et al.  The known unknowns of antigen processing and presentation , 2008, Nature Reviews Immunology.

[16]  M. Hulett,et al.  Bystander B cells rapidly acquire antigen receptors from activated B cells by membrane transfer , 2008, Proceedings of the National Academy of Sciences.

[17]  G. Randolph,et al.  Antigen presentation by monocytes and monocyte-derived cells. , 2008, Current opinion in immunology.

[18]  John Sidney,et al.  Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection , 2007, Nature Medicine.

[19]  J. Gauldie,et al.  Antigen Presentation by Exosomes Released from Peptide-Pulsed Dendritic Cells Is not Suppressed by the Presence of Active CTL1 , 2007, The Journal of Immunology.

[20]  Mark Yeager,et al.  Gap junction channel structure in the early 21st century: facts and fantasies. , 2007, Current opinion in cell biology.

[21]  Simon C Watkins,et al.  An Intracellular Serpin Regulates Necrosis by Inhibiting the Induction and Sequelae of Lysosomal Injury , 2007, Cell.

[22]  N. Hogg,et al.  CD8+ Dendritic Cells Use LFA-1 to Capture MHC-Peptide Complexes from Exosomes In Vivo1 , 2007, The Journal of Immunology.

[23]  S. Basta,et al.  The Cross‐priming Pathway: A Portrait of an Intricate Immune System , 2007, Scandinavian journal of immunology.

[24]  S. Powis,et al.  Open conformers: the hidden face of MHC-I molecules. , 2007, Trends in immunology.

[25]  E. Trombetta,et al.  Cross-talk between the endocytic pathway and the endoplasmic reticulum in cross-presentation by MHC class I molecules. , 2007, Current opinion in immunology.

[26]  Hidde L. Ploegh,et al.  Antigen Presentation and the Ubiquitin‐Proteasome System in Host–Pathogen Interactions , 2006, Advances in Immunology.

[27]  Kouhei Tsumoto,et al.  Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d) , 2006, Proceedings of the National Academy of Sciences.

[28]  L. Zitvogel,et al.  Prospects for exosomes in immunotherapy of cancer , 2006, Journal of cellular and molecular medicine.

[29]  K. Rock,et al.  Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. , 2006, Current opinion in immunology.

[30]  Eric O Long,et al.  Activation of NK Cells by an Endocytosed Receptor for Soluble HLA-G , 2005, PLoS biology.

[31]  M. Leppert,et al.  Allogeneic Hematopoietic Cell Transplantation for Metastatic Renal Cell Carcinoma after Nonmyeloablative Conditioning , 2004, Clinical Cancer Research.

[32]  S. Riddell,et al.  Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection. , 2004, Blood.

[33]  P. Cresswell,et al.  Cellular mechanisms governing cross-presentation of exogenous antigens , 2004, Nature Immunology.

[34]  H. Kiem,et al.  Efficient marking of murine long-term repopulating stem cells targeting unseparated marrow cells at low lentiviral vector particle concentration. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[35]  T. Neff,et al.  Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocol. , 2004, Blood.

[36]  D. Geraghty,et al.  HLA-F Surface Expression on B Cell and Monocyte Cell Lines Is Partially Independent from Tapasin and Completely Independent from TAP1 , 2003, The Journal of Immunology.

[37]  M. Desjardins,et al.  ER-mediated phagocytosis: a new membrane for new functions , 2003, Nature Reviews Immunology.

[38]  Yao-Tseng Chen,et al.  Cross-Presentation of HLA Class I Epitopes from Exogenous NY-ESO-1 Polypeptides by Nonprofessional APCs 1 , 2003, The Journal of Immunology.

[39]  G. Rimmelzwaan,et al.  Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B‐lymphoblastoid cells , 2001, Clinical and experimental immunology.

[40]  P. Lehner,et al.  Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  C. Melief,et al.  Antigen Loading of MHC Class I Molecules in the Endocytic Tract , 2001, Traffic.

[42]  Mark M. Davis,et al.  Melanocyte Destruction after Antigen-Specific Immunotherapy of Melanoma , 2000, The Journal of experimental medicine.

[43]  B. Deurs,et al.  Rab7: a key to lysosome biogenesis. , 2000, Molecular biology of the cell.

[44]  P. A. Biro,et al.  HLA-F Is a Predominantly Empty, Intracellular, TAP-Associated MHC Class Ib Protein with a Restricted Expression Pattern1 , 2000, The Journal of Immunology.

[45]  J. Neefjes,et al.  Recycling MHC class I molecules and endosomal peptide loading. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Hubbard,et al.  Isolation of Rat Hepatocyte Plasma Membrane Sheets and Plasma Membrane Domains , 1999, Current protocols in cell biology.

[47]  M. Davis,et al.  Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. , 1999, Journal of immunology.

[48]  J. Hansen,et al.  Definition of the gene encoding the minor histocompatibility antigen HA-1 and typing for HA-1 from genomic DNA. , 1998, Tissue antigens.

[49]  M. Llano,et al.  HLA‐E‐bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA‐G‐derived nonamer , 1998, European journal of immunology.

[50]  M. Llano,et al.  HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  R. Tampé,et al.  A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. , 1997, Science.

[52]  A Sette,et al.  Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues. , 1996, Journal of immunology.

[53]  P. L. Campbell,et al.  EEA1, an Early Endosome-Associated Protein. , 1995, The Journal of Biological Chemistry.

[54]  S. Tonegawa,et al.  TAP1‐independent loading of class I molecules by exogenous viral proteins , 1995, European journal of immunology.

[55]  C. Watts,et al.  Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments , 1990, Nature.

[56]  O. Majdic,et al.  Activated human T lymphocytes express MHC class I heavy chains not associated with beta 2-microglobulin , 1990, The Journal of experimental medicine.

[57]  S. Riddell,et al.  The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. , 1990, Journal of immunological methods.

[58]  J. Yewdell,et al.  Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design. , 2005, Annual review of immunology.

[59]  P. Guermonprez,et al.  Pathways for antigen cross presentation , 2004, Springer Seminars in Immunopathology.

[60]  S. Riddell,et al.  In vivo migration and function of transferred HIV-1-specific cytotoxic T cells , 1999, Nature Medicine.

[61]  K. Rock,et al.  Antigen processing and presentation by the class I major histocompatibility complex. , 1996, Annual review of immunology.

[62]  J. Monaco,et al.  A molecular model of MHC class-I-restricted antigen processing. , 1992, Immunology today.

[63]  R. Brady,et al.  [116] β-Hexosaminidase A from human placenta , 1972 .